Plus Therapeutics PSTV
Last Price
52 Week Range
$0.16 - $2.31
Next Earnings Date
Mar 26 2026 (Estimate)
Next Earnings Date
Mar 26 2026 (Est.)
Last Price
PSTV Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Plus Therapeutics, Inc. | 8-K | February 13, 2026 | |
Plus Therapeutics, Inc. | 8-K | January 22, 2026 | |
Plus Therapeutics, Inc. | 8-K | January 16, 2026 | |
Plus Therapeutics, Inc. | 8-K | November 17, 2025 | |
Plus Therapeutics, Inc. | 8-K | October 30, 2025 | |
Plus Therapeutics, Inc. | 10-Q | October 30, 2025 | |
Plus Therapeutics, Inc. | 8-K | October 21, 2025 | |
Plus Therapeutics, Inc. | 8-K | August 26, 2025 | |
Plus Therapeutics, Inc. | 10-Q | August 14, 2025 | |
Plus Therapeutics, Inc. | 8-K | August 14, 2025 | |
Plus Therapeutics, Inc. | 8-K | August 14, 2025 | |
Plus Therapeutics, Inc. | 8-K | August 13, 2025 | |
Plus Therapeutics, Inc. | 8-K | August 12, 2025 | |
Plus Therapeutics, Inc. | DEFA14A | August 1, 2025 | |
Plus Therapeutics, Inc. | DEF 14A | July 21, 2025 | |
Plus Therapeutics, Inc. | ARS | July 21, 2025 | |
Plus Therapeutics, Inc. | 8-K | July 18, 2025 | |
Plus Therapeutics, Inc. | PRE 14A | July 11, 2025 | |
Plus Therapeutics, Inc. | 8-K | June 20, 2025 | |
Plus Therapeutics, Inc. | 8-K | June 17, 2025 | |
Plus Therapeutics, Inc. | 8-K | June 6, 2025 | |
Plus Therapeutics, Inc. | 10-Q | May 30, 2025 | |
Plus Therapeutics, Inc. | 8-K | May 30, 2025 | |
Plus Therapeutics, Inc. | 8-K | May 23, 2025 | |
Plus Therapeutics, Inc. | 8-K | May 19, 2025 | |
Plus Therapeutics, Inc. | 8-K | May 2, 2025 | |
Plus Therapeutics, Inc. | DEFA14A | May 1, 2025 | |
Plus Therapeutics, Inc. | 8-K | April 18, 2025 | |
Plus Therapeutics, Inc. | DEF 14A | April 10, 2025 | |
Plus Therapeutics, Inc. | 10-K | March 31, 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.